Clinical trial
Identifying Targets of Maladaptive Metabolic Responses in Heart Failure
NCT03032627 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identifying Targets of Maladaptive Metabolic Responses in Heart Failure
- Lead sponsor
- AdventHealth Translational Research Institute
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 20, 2017
- Completion date
- December 31, 2025
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.